Search Results 1271-1280 of 15590 for Orange Peel tea

1. A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis - Mayo Clinic

   White blood cell count > 25 x 10e9/L or > 10% peripheral blood blasts; · Other invasive malignancies within the last 3 years, except non- melanoma skin cancer ...

2. Study of TERN-601 in Adults with Overweight or Obesity - Mayo Clinic

   ... skin cancer, in situ carcinoma of the cervix, ductal carcinoma in situ [DCIS] of the breast, or in situ prostate cancer, eg, high-grade prostatic ...

3. Androgen-Deprivation Therapy And Radiation Therapy In Treating Patients With Prostate Cancer - Mayo Clinic

   ... skin cancer) malignancy unless disease-free for a minimum of 3 years (1,095 days) and not in the pelvis - E.g., carcinoma in situ of the oral cavity is ...

4. An Investigational Immuno-therapy Study Of Nivolumab, Compared To Placebo, In Patients With Bladder Or Upper Urinary Tract Cancer, Following Surgery To Remove The Cancer - Mayo Clinic

   An Investigational Immuno-therapy Study Of Nivolumab, Compared To Placebo, In Patients With Bladder Or Upper Urinary Tract Cancer, Following Surgery To Remove ...

5. Gastroenterology and Hepatology - Clinical trials

   This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver diseases primary ...

6. Daratumumab Retreatment In Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV) - Mayo Clinic

   Further exceptions are squamous and basal cell carcinomas of the skin and carcinoma in situ of the cervix, or breast, or other non-invasive lesion, that in ...

7. A Study To Assess The Safety And Tolerability Of CFT8634 In Locally Advanced Or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma And SMARCB1-Null Tumors - Mayo Clinic

   Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...

8. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   No history of prior malignancy except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or other cancer for which the ...

9. Insulin Regulation of Lipolysis and Lipolysis Proteins - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. S1304, Carfilzomib And Dexamethasone For Treating Patients With Relapsed Or Refractory Myeloma - Mayo Clinic

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, work ...